Spots Global Cancer Trial Database for Master Rollover Protocol for Continued Safety Assessment of Study Drug
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Master Rollover Protocol for Continued Safety Assessment of Study Drug
Official Title: Master Rollover Protocol for Continued Safety Assessment of Study Drug
Study ID: NCT02632994
Conditions
Study Description
Brief Summary: This study is for patients who have participated in a previous study and who continue to receive benefit to have continued access to study drug and/or treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UCLA Medical Center, Torrance, California, United States
Fort Wayne Oncology & Hematology, Fort Wayne, Indiana, United States
Sarah Cannon Cancer Center, Nashville, Tennessee, United States
Contact Details
Name: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT -5 hours, EST)
Affiliation: Eli Lilly and Company
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
